What is Foundayo?
Foundayo is a once-daily tablet containing orforglipron. In the UK it's licensed for weight management in adults with a BMI of 30 or more, or 27 to 29.9 with at least one weight-related health condition, alongside a reduced-calorie diet and more physical activity. It's also licensed for type 2 diabetes.1 We only prescribe it for weight management in adults.
The MHRA authorised it in August 2026, making the UK the first country in Europe to approve orforglipron.3
It comes in six strengths: 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg and 17.2mg. You take one tablet a day.1
Does Foundayo work for weight loss?
For most people, yes. In ATTAIN-1, 3,127 adults with obesity but not diabetes took orforglipron or a placebo every day for 72 weeks, alongside diet and activity support. Average weight loss was 7.5% on 6mg, 8.4% on 12mg and 11.2% on 36mg, against 2.1% on placebo.7
On the 36mg dose, 54.6% of people lost at least 10% of their weight and 18.4% lost at least 20%, against 12.9% and 2.8% on placebo.7 The trial was funded by Eli Lilly, which makes Foundayo.
Those trial doses don't match the tablet strengths sold in the UK. The licence says the 5.5mg, 9mg and 17.2mg tablets give the same levels of orforglipron in the body as 6mg, 12mg and 36mg capsules.1
You may see slightly higher figures for the same trial in the Foundayo licence, such as 12.4% on 36mg. Those are worked out as if everyone had kept taking it, so they describe what the medicine can do rather than what happened to everyone who started.1
What happens if you stop Foundayo?
We don't know yet. We couldn't find a published trial that stopped orforglipron and followed what happened to people's weight afterwards.
With the weekly injections, most of the weight came back. People regained about two thirds of the weight they had lost within a year of stopping semaglutide.11 In a trial of tirzepatide, people switched to a placebo put 14.0% back on over a year.12
Until there's evidence for orforglipron, it's safest to assume the same, and to plan any stop with your prescriber.
How does Foundayo work?
Orforglipron acts on the GLP-1 receptor, the same target as Wegovy. It works on the parts of the brain that control appetite, and in type 2 diabetes it lowers blood sugar when it's high.3
Unlike Wegovy and Mounjaro, it isn't a peptide. It's a small-molecule medicine taken as a tablet, at any time of day, with no rules about food or water.17
Because it lowers blood sugar, the risk of a hypo goes up if you also take insulin or a sulfonylurea for diabetes.1
How to get Foundayo on prescription in the UK
Foundayo isn't available on the NHS yet. NICE will assess it before the NHS decides whether to offer it.3
Privately, a prescriber has to assess you first. It's a prescription-only medicine, and the MHRA advises getting it from a registered pharmacy rather than an unregulated seller.3 With us, that works like this:
- You answer our online questions about your health, your weight history and any medicines you take.
- We confirm your weight independently, by video call or from a recent weight recorded by your GP. Pharmacies that prescribe at a distance have to verify it rather than take it on trust.5
- With your consent, our prescriber checks your Summary Care Record, and we let your GP know what we've prescribed.
- If Foundayo is suitable, we dispense it and post it in plain packaging.
Not every consultation ends in a prescription. If treatment isn't approved, the pending charge on your card is cancelled and you're refunded in full.
Who can use our Foundayo service?
This service is for adults whose weight is in the range Foundayo is licensed for, and who can be looked after safely at a distance.
This service may be suitable if
- You're aged 18 to 65.
- Your BMI is 30 or more, or 27 to 29.9 with a weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes, sleep apnoea or heart disease.1
- You're registered with a UK GP and happy for us to contact them.
- You're already using a weight loss injection and want to switch. We'll ask for your current dose, when you last injected and where it came from.
We can't prescribe Foundayo if
- You're pregnant, breastfeeding, having IVF, or planning a pregnancy in the next 3 months.
- You have type 1 diabetes.
- You've ever had pancreatitis.
- You or a close relative have had medullary thyroid cancer or MEN2.
- You currently have an eating disorder.
- You'd be taking it at the same time as another GLP-1 medicine, such as Wegovy, Mounjaro or Ozempic.
Some of these are stricter than the licence. They're the rules for our online service.
Tell our prescriber before treatment if
- You have type 2 diabetes, especially if you use insulin or a sulfonylurea such as gliclazide.1
- You have diabetic eye disease (retinopathy).1
- You have severe stomach or bowel problems.1
- You've had gallstones or other gallbladder problems.1
- You have kidney or liver problems.
- You have low blood pressure, faint easily, or take blood pressure medicines.1
- You have severe heart failure.1
- You take any of the medicines listed in 'Foundayo, operations and other medicines' below.
- You have an operation or a procedure under sedation coming up.1
- You've had an eating disorder in the past, or you have depression or another mental health condition.
Foundayo results: when can changes appear?
Give it a proper run. The dose goes up no faster than every 30 days, from 0.8mg to 2.5mg and then 5.5mg, so it takes at least 2 months to reach 5.5mg. That's the lowest of the doses tested for weight loss.17
ATTAIN-1 measured weight loss at 72 weeks, so the trial figures describe well over a year of treatment.7
Weigh yourself once a week, on the same scales at the same time of day, so you're comparing like with like.
Does Foundayo make you feel sick?
It often does at first. Feeling sick, constipation, diarrhoea, being sick, indigestion and stomach pain are all very common, which means they affect more than 1 in 10 people.1
In ATTAIN-1, side effects led between 5% and 10% of people on orforglipron to stop, depending on the dose, against 3% on placebo.7
If sickness is making it hard to eat or drink, do not push on to the next dose increase. Talk to us first. The dose only goes up after at least 30 days, it can stay where it is for longer, and the licence allows it to be lowered or stopped if stomach side effects are severe.1
Drink enough fluids. Losing fluid through vomiting or diarrhoea can cause dehydration and, occasionally, kidney problems.2
Our guide, Feeling sick on Mounjaro or Wegovy: when to hold your dose, was written for the weekly injections. Its advice on eating and drinking applies to Foundayo too, but its advice on holding a weekly dose doesn't.
How to take Foundayo tablets
| Step | Daily dose |
|---|---|
| 1 | 0.8mg, for at least 30 days |
| 2 | 2.5mg, for at least 30 days |
| 3 | 5.5mg |
| 4 to 6, if needed | 9mg, then 14.5mg, then 17.2mg, each for at least 30 days before the next |
| Maximum | 17.2mg a day |
The schedule comes from the Foundayo licence.1 Your prescriber may keep you on a dose for longer, and not everyone needs the higher doses.
- Take one tablet a day, at any time of day, with or without food.2
- Swallow it whole. Do not break, crush or chew it.2
- Do not take more than one tablet a day.2
- If you forget a dose, take it as soon as you remember. Do not take a double dose to make up for it.2
- If you take too much, speak to a doctor straight away. Too much can make you feel or be sick.2
- Do not change your dose or stop without talking to us first.
Storing your tablets. Foundayo doesn't need a fridge. Keep it in the original pack to protect it from light.1
The leaflet in the pack has the full instructions. Read it before your first dose.2
Side effects of Foundayo
Reported side effects
Very common (more than 1 in 10 people): feeling sick, constipation, diarrhoea, being sick, indigestion and stomach pain.1
Common (up to 1 in 10 people): dizziness, headache, a fast heartbeat, low blood pressure, bloating, burping, reflux, wind, gallstones, hair loss, tiredness, and raised amylase or lipase in blood tests. In people with type 2 diabetes, low blood sugar is very common alongside insulin and common alongside a sulfonylurea.1
Low blood pressure happened more often in people who also took blood pressure medicines.1
Our guide, Mounjaro, Wegovy and hair loss, was written for the weekly injections, but it explains what's known about hair loss with this group of medicines.
When to stop and get help
Most side effects aren't a reason to worry. These are.
Call 999 or go to A&E if you have:
- Breathing problems, wheezing, swelling of your face or throat, a fast heartbeat, pale and cold skin, or you feel dizzy or weak. This could be a severe allergic reaction.2
- Severe pain in your stomach and back that doesn't go away. This can be a sign of an inflamed pancreas (acute pancreatitis).12
Get advice the same day if:
- You can't keep fluids down, or you're losing a lot of fluid through vomiting or diarrhoea. Dehydration can lead to kidney problems, which have occasionally needed dialysis.2
- You have pain in your upper stomach, yellowing of your skin or eyes, pale clay-coloured poo or a fever. These can be signs of gallbladder problems.2
- You keep feeling dizzy or faint. Low blood pressure is a common side effect, especially alongside blood pressure medicines.1
These symptoms don't always mean something serious is wrong, but they need checking. You can report any side effect to the MHRA Yellow Card scheme.6
Foundayo, the pill, pregnancy and breastfeeding
The pill. Foundayo may make the pill less effective. If you take the pill, use condoms as well, or switch to a method that isn't a pill, such as the implant or a coil, for 30 days after starting Foundayo and for 30 days after every dose increase.12
Pregnancy. Do not use Foundayo if you're pregnant, and use contraception while you're taking it. If you're planning a pregnancy, stop it at least 3 weeks before.12 If you get pregnant while taking it, stop and speak to us or your GP straight away.
Breastfeeding. Foundayo shouldn't be used while you're breastfeeding.12
Foundayo, operations and other medicines
If you're having an operation or a procedure under sedation, such as an endoscopy, tell the team, including the anaesthetist, that you take Foundayo. Like other GLP-1 medicines, it carries a possible risk of stomach contents getting into the lungs under a general anaesthetic or deep sedation.1 Do not stop it without discussing it with them first.
Tell us about everything you take, including medicines you buy and herbal remedies. The leaflet names these:2
- Medicines that can raise Foundayo levels: clarithromycin (an antibiotic), itraconazole and ketoconazole (antifungals), and ritonavir and telaprevir. With some of these the dose can't go above 9mg, and others shouldn't be taken with it at all.12
- Medicines that can lower Foundayo levels, so it may not work as well: carbamazepine, phenytoin, rifampicin, bosentan, efavirenz and St John's wort.2
- Medicines whose levels Foundayo can raise: simvastatin, rosuvastatin and topotecan. If you take simvastatin, its dose should be halved.12
- Insulin or a sulfonylurea, as the risk of low blood sugar goes up.1
- Blood pressure medicines, as low blood pressure is more likely.1
- Any other GLP-1 medicine, which shouldn't be taken at the same time.
If you're thinking of switching between Foundayo and another weight loss medicine, speak to a prescriber first. The MHRA warns that switching without advice can make side effects more likely or the treatment less effective.4
How does Foundayo compare with Wegovy and Mounjaro?
No trial has compared Foundayo with Wegovy or Mounjaro directly, and setting separate trials side by side is unreliable. With that caveat, average weight loss was lower: up to 11.2% in ATTAIN-1, against 14.9% for Wegovy in STEP 1 and up to 20.9% for Mounjaro in SURMOUNT-1.7910
What Foundayo changes is the practical side. It's a daily tablet rather than a weekly injection, it doesn't need a fridge, and there are no rules about food or water.1
ATTAIN-MAINTAIN tested switching to orforglipron after losing weight on the injections. Over a year, people who switched from semaglutide kept 79.3% of the weight they had lost, against 37.6% of those switched to a placebo. People who switched from tirzepatide kept 74.7%, against 49.2%.8
That still meant putting some weight back on: about 1kg on average after semaglutide and about 5kg after tirzepatide. The trial was funded by Eli Lilly, which makes Foundayo and Mounjaro.8
Whether to switch, and how, is a decision for you and a prescriber. Our guide, Wegovy vs Mounjaro: which is better for weight loss?, compares the two injections.
Support after you start
Foundayo is a long-term treatment, and you can come back to us with questions at any point.
- If sickness, diarrhoea or constipation is getting in the way of eating and drinking, tell us rather than waiting for your next order.
- Tell us before you start any new medicine, including antibiotics, antifungals and herbal remedies, as some change how Foundayo works.
- Tell us before your next order if you have an operation coming up or are planning a pregnancy.
- Do not increase, lower or stop your dose on your own. Ask us and the prescriber will advise.
- If something doesn't feel right, get in touch. Our pharmacists are happy to talk it through.
Foundayo FAQs
Can I buy Foundayo without a prescription?
No. Foundayo is a prescription-only medicine, so a prescriber has to assess you first. The MHRA advises getting it only from a registered pharmacy.3
Can I get Foundayo on the NHS?
Not yet. It isn't currently available on the NHS, and NICE will assess it first.3
How much weight will I lose on Foundayo?
Nobody can tell you that in advance. In ATTAIN-1 the average was 7.5% to 11.2% over 72 weeks depending on the dose, against 2.1% on placebo. Those are averages, and your result may be higher or lower.7
Do I need to take Foundayo on an empty stomach?
No. You can take it at any time of day, and there are no rules about food or water.1
Does Foundayo need to go in the fridge?
No. It doesn't need any special temperature. Keep it in the original pack to protect it from light.1
Do I need extra contraception on Foundayo?
Yes, if you take the pill. Use condoms as well, or a method that isn't a pill, for 30 days after starting and for 30 days after each dose increase.1
What happens if I miss a dose?
Take it as soon as you remember. Do not take two tablets to make up for it.2
Can I switch from Mounjaro or Wegovy to Foundayo?
Yes, if a prescriber agrees. In ATTAIN-MAINTAIN, people who switched from semaglutide kept 79.3% of the weight they'd lost over a year, and people who switched from tirzepatide kept 74.7%.8 Tell us your current dose and when you last injected.
Is Foundayo as effective as the injections?
Does Foundayo cause hair loss?
It can. Hair loss is listed as a common side effect.1 Our guide to hair loss on Mounjaro and Wegovy explains what's known about hair loss with this group of medicines.
Can I take Foundayo with antibiotics?
Do I need to stop Foundayo before an operation?
Do not stop it on your own. Tell the team doing the operation, including the anaesthetist, that you take Foundayo, and follow their advice.1
Clinical sources and further information
This page is a treatment overview and does not replace the leaflet supplied with your pack or individual advice from a prescriber.
Regulatory and clinical guidance
- eMC: Foundayo film-coated tablets summary of product characteristics, last updated 14 August 2026 (accessed 13 November 2026)
- eMC: Foundayo patient information leaflet, revised August 2026 (accessed 13 November 2026)
- MHRA: UK first in Europe to authorise orforglipron for weight management and type 2 diabetes, 10 August 2026 (accessed 13 November 2026)
- MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know, updated 5 February 2026 (accessed 13 November 2026)
- GPhC: guidance for registered pharmacies providing pharmacy services at a distance, February 2025 (accessed 13 November 2026)
- MHRA Yellow Card scheme
Published studies
- ATTAIN-1: 2025 randomised trial of orforglipron in 3,127 adults with obesity without diabetes. Wharton S et al. N Engl J Med. 2025. DOI: 10.1056/NEJMoa2511774 (accessed 13 November 2026)
- ATTAIN-MAINTAIN: 2026 randomised trial of switching from semaglutide or tirzepatide injections to orforglipron in 376 adults. Aronne LJ et al. Nat Med. 2026. DOI: 10.1038/s41591-026-04386-7 (accessed 13 November 2026)
- STEP 1: 2021 randomised trial of semaglutide 2.4mg in 1,961 adults without diabetes. Wilding JPH et al. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2032183 (accessed 13 November 2026)
- SURMOUNT-1: 2022 randomised trial of tirzepatide in 2,539 adults without diabetes. Jastreboff AM et al. N Engl J Med. 2022. DOI: 10.1056/NEJMoa2206038 (accessed 13 November 2026)
- STEP 1 extension: weight regain in the year after stopping semaglutide. Wilding JPH et al. Diabetes Obes Metab. 2022. DOI: 10.1111/dom.14725 (accessed 13 November 2026)
- SURMOUNT-4: 2024 randomised trial of continuing or stopping tirzepatide in 670 adults. Aronne LJ et al. JAMA. 2024. DOI: 10.1001/jama.2023.24945 (accessed 13 November 2026)
